UBS AM’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-13,455
| Closed | -$95.7K | – | 2894 |
|
|
2019
Q1 | $95.7K | Sell |
13,455
-96,706
| -88% | -$688K | ﹤0.01% | 2567 |
|
|
2018
Q4 | $941K | Sell |
110,161
-148,132
| -57% | -$1.27M | ﹤0.01% | 1783 |
|
|
2018
Q3 | $5.17M | Buy |
258,293
+50,319
| +24% | +$1.01M | ﹤0.01% | 1133 |
|
|
2018
Q2 | $5.37M | Buy |
207,974
+20,495
| +11% | +$529K | ﹤0.01% | 1128 |
|
|
2018
Q1 | $4.48M | Sell |
187,479
-9,619
| -5% | -$230K | ﹤0.01% | 1188 |
|
|
2017
Q4 | $6.68M | Buy |
+197,098
| New | +$6.68M | 0.01% | 1019 |
|
|
2016
Q3 | – | Sell |
-17,110
| Closed | -$259K | – | 2608 |
|
|
2016
Q2 | $259K | Sell |
17,110
-12,171
| -42% | -$184K | ﹤0.01% | 2297 |
|
|
2016
Q1 | $423K | Buy |
29,281
+13,115
| +81% | +$189K | ﹤0.01% | 2014 |
|
|
2015
Q4 | $458K | Sell |
16,166
-4,674
| -22% | -$132K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $349K | Sell |
20,840
-1,533
| -7% | -$25.7K | ﹤0.01% | 2207 |
|
|
2015
Q2 | $587K | Buy |
+22,373
| New | +$587K | ﹤0.01% | 1981 |
|